These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32120306)

  • 1. Gaucher disease status and treatment assessment: pilot study using magnetic resonance spectroscopy bone marrow fat fractions in pediatric patients.
    Degnan AJ; Ho-Fung VM; Wang DJ; Ficicioglu C; Jaramillo D
    Clin Imaging; 2020 Jul; 63():1-6. PubMed ID: 32120306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift MR imaging--initial experience.
    Maas M; van Kuijk C; Stoker J; Hollak CE; Akkerman EM; Aerts JF; den Heeten GJ
    Radiology; 2003 Nov; 229(2):554-61. PubMed ID: 14526090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of Bone Marrow Involvement in Treated Gaucher Disease With Proton MR Spectroscopy: Correlation With Bone Marrow MRI Scores and Clinical Status.
    Jaramillo D; Bedoya MA; Wang DJ; Pena AH; Delgado J; Jaimes C; Ho-Fung V; Kaplan P
    AJR Am J Roentgenol; 2015 Jun; 204(6):1296-302. PubMed ID: 26001241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fat fraction quantification of bone marrow in the lumbar spine using the LiverLab assessment tool in healthy adult volunteers and patients with Gaucher disease.
    Gan C; Robertson PL; Lai JKC; Szer J
    Intern Med J; 2023 Jul; 53(7):1163-1169. PubMed ID: 35762150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marrow adiposity assessed on transiliac crest biopsy samples correlates with noninvasive measurement of marrow adiposity by proton magnetic resonance spectroscopy ((1)H-MRS) at the spine but not the femur.
    Cohen A; Shen W; Dempster DW; Zhou H; Recker RR; Lappe JM; Kepley A; Kamanda-Kosseh M; Bucovsky M; Stein EM; Nickolas TL; Shane E
    Osteoporos Int; 2015 Oct; 26(10):2471-8. PubMed ID: 25986383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dixon quantitative chemical shift imaging is a sensitive tool for the evaluation of bone marrow responses to individualized doses of enzyme supplementation therapy in type 1 Gaucher disease.
    Hollak C; Maas M; Akkerman E; den Heeten A; Aerts H
    Blood Cells Mol Dis; 2001; 27(6):1005-12. PubMed ID: 11831867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of velaglucerase alfa on bone marrow burden score in adult patients with type 1 Gaucher disease: 7-year follow-up.
    Elstein D; Haims AH; Zahrieh D; Cohn GM; Zimran A
    Blood Cells Mol Dis; 2014; 53(1-2):56-60. PubMed ID: 24581483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraobserver and interobserver variability of the bone marrow burden (BMB) score for the assessment of disease severity in Gaucher disease. Possible impact of reporting experience.
    Lai JKC; Robertson PL; Goh C; Szer J
    Blood Cells Mol Dis; 2018 Feb; 68():121-125. PubMed ID: 28187999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Bone Marrow Infiltration in Non-Neuropathic Gaucher Disease Patients with Use of Whole-Body MRI--A Retrospective Data Analysis.
    Laudemann K; Moos L; Mengel KE; Lollert A; Reinke J; Brixius-Huth M; Wagner D; Düber C; Staatz G
    Rofo; 2015 Dec; 187(12):1093-8. PubMed ID: 26200566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semiquantitative assessment of skeletal response to enzyme replacement therapy for Gaucher's disease using the bone marrow burden score.
    Robertson PL; Maas M; Goldblatt J
    AJR Am J Roentgenol; 2007 Jun; 188(6):1521-8. PubMed ID: 17515371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow involvement in Gaucher disease at MRI : what long-term evolution can we expect under enzyme replacement therapy?
    Fedida B; Touraine S; Stirnemann J; Belmatoug N; Laredo JD; Petrover D
    Eur Radiol; 2015 Oct; 25(10):2969-75. PubMed ID: 25875285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of skeletal involvement in adults with type I Gaucher's disease: fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameter.
    Maas M; Hollak CE; Akkerman EM; Aerts JM; Stoker J; Den Heeten GJ
    AJR Am J Roentgenol; 2002 Oct; 179(4):961-5. PubMed ID: 12239046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow fat content in 70 adolescent girls with anorexia nervosa: Magnetic resonance imaging and magnetic resonance spectroscopy assessment.
    Ecklund K; Vajapeyam S; Mulkern RV; Feldman HA; O'Donnell JM; DiVasta AD; Gordon CM
    Pediatr Radiol; 2017 Jul; 47(8):952-962. PubMed ID: 28432403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of fat fraction in lumbar vertebrae: correlation with age and implications for bone marrow dosimetry in molecular radiotherapy.
    Salas-Ramirez M; Tran-Gia J; Kesenheimer C; Weng AM; Kosmala A; Heidemeier A; Köstler H; Lassmann M
    Phys Med Biol; 2018 Jan; 63(2):025029. PubMed ID: 29130901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of IDEAL-IQ in Quantifying Femoral Bone Marrow Involvement in Gaucher Disease.
    Hou B; Cidanwangjiu ; Zhang H; Wang F; Qiu Z; Zhang Y; Jin Z
    J Comput Assist Tomogr; 2023 Jul-Aug 01; 47(4):637-642. PubMed ID: 37382507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of treatment response to enzyme replacement therapy with Velaglucerase alfa in patients with Gaucher disease using whole-body magnetic resonance imaging.
    Laudemann K; Moos L; Mengel E; Lollert A; Hoffmann C; Brixius-Huth M; Wagner D; Düber C; Staatz G
    Blood Cells Mol Dis; 2016 Mar; 57():35-41. PubMed ID: 26852653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity of bone marrow involvement in patients with Gaucher's disease evaluated by scintigraphy with 99mTc-sestamibi.
    Mariani G; Filocamo M; Giona F; Villa G; Amendola A; Erba P; Buffoni F; Copello F; Pierini A; Minichilli F; Gatti R; Brady RO
    J Nucl Med; 2003 Aug; 44(8):1253-62. PubMed ID: 12902415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does vertebral bone marrow fat content correlate with abdominal adipose tissue, lumbar spine bone mineral density, and blood biomarkers in women with type 2 diabetes mellitus?
    Baum T; Yap SP; Karampinos DC; Nardo L; Kuo D; Burghardt AJ; Masharani UB; Schwartz AV; Li X; Link TM
    J Magn Reson Imaging; 2012 Jan; 35(1):117-24. PubMed ID: 22190287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-parametric MR imaging using apparent diffusion coefficient and fat fraction in quantification of bone marrow in pediatrics with Gaucher disease.
    Razek AAKA; Abdalla A; Barakat T; El-Taher H; Ali K
    Clin Imaging; 2018; 51():318-322. PubMed ID: 29958157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardization of MRI and Scintigraphic Scores for Assessing the Severity of Bone Marrow Involvement in Adult Patients With Type 1 Gaucher Disease.
    Mariani G; Perri M; Minichilli F; Ortori S; Linari S; Giona F; Di Rocco M; Cappellini MD; Guidoccio F; Erba PA
    AJR Am J Roentgenol; 2016 Jun; 206(6):1245-52. PubMed ID: 27057587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.